Cargando…

Discovery of Natural Products as Novel and Potent FXR Antagonists by Virtual Screening

Farnesoid X receptor (FXR) is a member of nuclear receptor family involved in multiple physiological processes through regulating specific target genes. The critical role of FXR as a transcriptional regulator makes it a promising target for diverse diseases, especially those related to metabolic dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diao, Yanyan, Jiang, Jing, Zhang, Shoude, Li, Shiliang, Shan, Lei, Huang, Jin, Zhang, Weidong, Li, Honglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936786/ https://www.ncbi.nlm.nih.gov/pubmed/29761098 http://dx.doi.org/10.3389/fchem.2018.00140

Ejemplares similares

Pharmacophore modeling and virtual screening studies for discovery of novel farnesoid X receptor (FXR) agonists
por: Zhao, Shizhen, et al.
Publicado: (2021)

Discovery of 9,11-Seco-Cholesterol Derivatives as Novel FXR Antagonists
por: Zhou, Jia-Xu, et al.
Publicado: (2022)

Jacarelhyperol A induced apoptosis in leukaemia cancer cell through inhibition the activity of Bcl-2 proteins
por: Zhang, Shoude, et al.
Publicado: (2014)

Retraction Note: Jacarelhyperol A induced apoptosis in leukaemia cancer cell through inhibition the activity of Bcl-2 proteins
por: Zhang, Shoude, et al.
Publicado: (2022)

Systematic Analysis of the Multiple Bioactivities of Green Tea through a Network Pharmacology Approach
por: Zhang, Shoude, et al.
Publicado: (2014)

Discovery of New α-Glucosidase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation
por: Liu, Shan-Kui, et al.
Publicado: (2021)

Discovery of novel inhibitors of RNA silencing suppressor P19 based on virtual screening
por: Hu, Fan, et al.
Publicado: (2018)

Structure Optimization of 12β-O-γ-Glutamyl Oleanolic Acid Derivatives Resulting in Potent FXR Antagonist/Modulator for NASH Therapy
por: Ma, Hao, et al.
Publicado: (2023)

Insights on FXR selective modulation. Speculation on bile acid chemical space in the discovery of potent and selective agonists
por: Sepe, Valentina, et al.
Publicado: (2016)

Discovery of novel and potent P2Y(14)R antagonists via structure-based virtual screening for the treatment of acute gouty arthritis
por: Wang, Weiwei, et al.
Publicado: (2020)

Discovery and characterization of naturally occurring potent inhibitors of catechol-O-methyltransferase from herbal medicines
por: Zhao, Dong-Fang, et al.
Publicado: (2021)

Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies
por: Xi, Lili, et al.
Publicado: (2023)

Virtual screening for the discovery of bioactive natural products
por: Rollinger, Judith M., et al.
Publicado: (2008)

Combination of Virtual Screening Protocol by in Silico toward the Discovery of Novel 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors
por: Fu, Ying, et al.
Publicado: (2018)

Discovery of 2-(4-Acrylamidophenyl)-Quinoline-4-Carboxylic Acid Derivatives as Potent SIRT3 Inhibitors
por: Hui, Qian, et al.
Publicado: (2022)

Predicting the Drug Safety for Traditional Chinese Medicine through a Comparative Analysis of Withdrawn Drugs Using Pharmacological Network
por: Xue, Mengzhu, et al.
Publicado: (2013)

Homology Modeling and Virtual Screening to Discover Potent Inhibitors Targeting the Imidazole Glycerophosphate Dehydratase Protein in Staphylococcus xylosus
por: Chen, Xing-Ru, et al.
Publicado: (2017)

Natural Product 2-Oxokolavenol Is a Novel FXR Agonist
por: Guo, Fusheng, et al.
Publicado: (2022)

Discovery of human TyrRS inhibitors by structure-based virtual screening, structural optimization, and bioassays
por: Huang, Shenzhen, et al.
Publicado: (2019)

A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer
por: Yao, Wenbo, et al.
Publicado: (2017)

Virtual Screening and Bioactivity Evaluation of Novel Androgen Receptor Antagonists From Anti-PCa Traditional Chinese Medicine Prescriptions
por: Han, Wenya, et al.
Publicado: (2020)

Discovery of 5,5′-Methylenedi-2,3-Cresotic Acid as a Potent Inhibitor of the Chemotactic Activity of the HMGB1·CXCL12 Heterocomplex Using Virtual Screening and NMR Validation
por: De Leo, Federica, et al.
Publicado: (2020)

Optical control of the nuclear bile acid receptor FXR with a photohormone
por: Morstein, Johannes, et al.
Publicado: (2019)

Dual-Specificity Phosphatase CDC25B Was Inhibited by Natural Product HB-21 Through Covalently Binding to the Active Site
por: Zhang, Shoude, et al.
Publicado: (2018)

Discovery and Identification of Pyrazolopyramidine Analogs as Novel Potent Androgen Receptor Antagonists
por: Wang, Lingyan, et al.
Publicado: (2018)

Discovery That Theonellasterol a Marine Sponge Sterol Is a Highly Selective FXR Antagonist That Protects against Liver Injury in Cholestasis
por: Renga, Barbara, et al.
Publicado: (2012)

Corrigendum: Dual-specificity phosphatase CDC25B was inhibited by natural product HB-21 through covalently binding to the active site
por: Zhang, Shoude, et al.
Publicado: (2022)

Discovery of potent and noncovalent KRAS(G12D) inhibitors: Structure-based virtual screening and biological evaluation
por: Wang, Yuting, et al.
Publicado: (2022)

Virtual screening–based discovery of AI-2 quorum sensing inhibitors that interact with an allosteric hydrophobic site of LsrK and their functional evaluation
por: Shi, Qianqian, et al.
Publicado: (2023)

Virtual Screening on Marine Natural Products for Discovering TMPRSS2 Inhibitors
por: Mahmudpour, Mehdi, et al.
Publicado: (2021)

Discovery of Cobimetinib as a novel A-FABP inhibitor using machine learning and molecular docking-based virtual screening
por: Yang, Shilun, et al.
Publicado: (2022)

Virtual Screening and Structure-Based Discovery of Indole Acylguanidines as Potent β-secretase (BACE1) Inhibitors
por: Zou, Yiquan, et al.
Publicado: (2013)

Structure-Based Virtual Screening of Ultra-Large Library Yields Potent Antagonists for a Lipid GPCR
por: Sadybekov, Arman A., et al.
Publicado: (2020)

Proteomics for the discovery of nuclear bile acid receptor FXR targets()
por: Gardmo, Cissi, et al.
Publicado: (2011)

Veratramine modulates AP-1-dependent gene transcription by directly binding to programmable DNA
por: Bai, Fang, et al.
Publicado: (2018)

Identifying novel selective PPO inhibitors through structure-based virtual screening and bio-evaluation
por: Zhao, Shan-Shan, et al.
Publicado: (2023)

BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination
por: Jung, Hyunkyung, et al.
Publicado: (2020)

Discovery of Bile Acid Derivatives as Potent ACE2 Activators by Virtual Screening and Essential Dynamics
por: Fiorillo, Bianca, et al.
Publicado: (2021)

FXR1 regulates transcription and is required for growth of human cancer cells with TP53/FXR2 homozygous deletion
por: Fan, Yichao, et al.
Publicado: (2017)

Identification of xanthine oxidase inhibitors through hierarchical virtual screening
por: Yang, Ying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fc5g6l905qvlrumge474a7ute3